title: Can amiodarone be restarted after amiodarone-induced thyrotoxicosis?
abstract: Thyrotoxicosis is a well-documented and studied complication of treatment with amiodarone, but little has been written about the risks and treatment of recurrent thyrotoxicosis upon re-exposure to amiodarone. One such case is outlined here and discussed by a panel of experts.
authors.affiliation: Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University, Columbus, OH, 43210, USA. ryan-7@medctr.osu.edu
authors.forename: Laura E
authors.initials: LE
authors.lastname: Ryan
authors.forename: Lewis E
authors.initials: LE
authors.lastname: Braverman
authors.forename: David S
authors.initials: DS
authors.lastname: Cooper
authors.forename: Paul W
authors.initials: PW
authors.lastname: Ladenson
authors.forename: Richard T
authors.initials: RT
authors.lastname: Kloos
mesh_terms: D000368:Aged; D000638:Amiodarone / Q000009:adverse effects* / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008499:Medical Records; D012008:Recurrence; D017180:Tachycardia, Ventricular / Q000188:drug therapy*; D013971:Thyrotoxicosis / Q000139:chemically induced* / Q000628:therapy
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone